OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
67
Results
Show all
Save search
Copy query
Show results for
Unknown
(67)
Publication Date
Release Date
2022
(15)
2025
(13)
2023
(9)
2021
(9)
2024
(7)
2020
(3)
2018
(3)
2015
(3)
2016
(2)
2017
(1)
2013
(1)
2009
(1)
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
Immediate stabilization of human blood for delayed quantification of endogenous thiols and disulfides.
Not available
S-EPMC4829439
|
biostudies-literature
Cite
Insulin administration: present strategies and future directions for a noninvasive (possibly more physiological) delivery.
Not available
S-EPMC4476457
|
biostudies-literature
Cite
Spectrum of Atazanavir-Selected Protease Inhibitor-Resistance Mutations.
Not available
S-EPMC9148044
|
biostudies-literature
Cite
Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS study.
Not available
S-EPMC12526715
|
biostudies-literature
Cite
Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream.
Not available
S-EPMC10800748
|
biostudies-literature
Cite
A Comprehensive Evaluation of Sdox, a Promising H
2
S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors.
Not available
S-EPMC8936434
|
biostudies-literature
Cite
Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study.
Not available
S-EPMC9321101
|
biostudies-literature
Cite
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study.
Not available
S-EPMC9719965
|
biostudies-literature
Cite
Accrual of organ damage in Behcet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study.
Not available
S-EPMC9670626
|
biostudies-literature
Cite
Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors.
Not available
S-EPMC6136871
|
biostudies-literature
Cite
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets